STOCK TITAN

[144] LeMaitre Vascular, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

LeMaitre Vascular, Inc. Form 144 reports a proposed sale of 2,500 common shares on NASDAQ through Morgan Stanley Smith Barney LLC with an aggregate market value of $235,000 and an approximate sale date of 08/08/2025. The filing lists 22,637,522 shares outstanding, showing the reported sale is a very small fraction of the companys outstanding stock.

The securities-to-be-sold were recorded as acquired by a stock option exercise on 08/08/2025 with payment in cash. The filing also discloses a prior sale by Bridget A Ross of 3,750 shares on 05/12/2025 for $312,000. Several filer identification fields (for example Filer CIK and Filer CCC) are not populated in the provided text. The signer affirms no undisclosed material adverse information.

LeMaitre Vascular, Inc. La Form 144 segnala una proposta di vendita di 2.500 azioni ordinarie su NASDAQ tramite Morgan Stanley Smith Barney LLC, per un valore di mercato complessivo di $235.000 e con data approssimativa di vendita indicata come 08/08/2025. Il deposito riporta 22.637.522 azioni in circolazione, mostrando che la vendita segnalata rappresenta una quota molto ridotta del capitale sociale della società.

I titoli da vendere risultano acquisiti mediante esercizio di un'opzione azionaria il 08/08/2025 con pagamento in contanti. La documentazione segnala inoltre una precedente vendita effettuata da Bridget A Ross di 3.750 azioni in data 05/12/2025 per $312.000. Alcuni campi identificativi del dichiarante (ad esempio Filer CIK e Filer CCC) non sono compilati nel testo fornito. Il firmatario dichiara l'assenza di informazioni materiali sfavorevoli non divulgate.

LeMaitre Vascular, Inc. El Form 144 informa de una propuesta de venta de 2.500 acciones ordinarias en NASDAQ a través de Morgan Stanley Smith Barney LLC, con un valor de mercado agregado de $235,000 y una fecha aproximada de venta de 08/08/2025. La presentación indica 22.637.522 acciones en circulación, lo que muestra que la venta notificada constituye una fracción muy pequeña del capital social de la compañía.

Los valores a vender constan como adquiridos mediante el ejercicio de una opción sobre acciones el 08/08/2025, con pago en efectivo. El documento también revela una venta previa por parte de Bridget A Ross de 3.750 acciones el 05/12/2025 por $312,000. Varios campos de identificación del declarante (por ejemplo Filer CIK y Filer CCC) no aparecen completados en el texto facilitado. El firmante afirma que no existen informaciones adversas materiales no divulgadas.

LeMaitre Vascular, Inc.Form 144Morgan Stanley Smith Barney LLC를 통해 NASDAQ에서 2,500 보통주 매각을 제안했음을 보고하며, 총 시가가 $235,000이고 예상 매각일은 08/08/2025로 명시되어 있습니다. 제출서류에는 22,637,522주가 유통 중으로 기재되어 있어 보고된 매각이 회사 발행주식의 매우 작은 부분임을 보여줍니다.

매도 예정 증권은 스톡옵션 행사08/08/2025에 취득된 것으로 기록되어 있으며, 대금은 현금으로 지급되었습니다. 서류는 또한 Bridget A Ross05/12/20253,750주를 $312,000에 매각한 사실도 공개하고 있습니다. 제출자 식별 필드(예: Filer CIK 및 Filer CCC) 중 일부가 제공된 텍스트에 기입되어 있지 않습니다. 서명자는 공개되지 않은 중대한 불리한 정보가 없음을 확인합니다.

LeMaitre Vascular, Inc. Le Form 144 signale une proposition de vente de 2 500 actions ordinaires sur le NASDAQ par l'intermédiaire de Morgan Stanley Smith Barney LLC, pour une valeur de marché totale de 235 000 $ et une date approximative de vente le 08/08/2025. Le dossier indique 22 637 522 actions en circulation, montrant que la vente déclarée ne représente qu'une très petite fraction du capital social de la société.

Les titres à vendre sont indiqués comme ayant été acquis par exercice d'une option sur actions le 08/08/2025, avec paiement en espèces. Le dossier révèle également une vente antérieure réalisée par Bridget A Ross de 3 750 actions le 05/12/2025 pour 312 000 $. Plusieurs champs d'identification du déclarant (par exemple Filer CIK et Filer CCC) ne sont pas remplis dans le texte fourni. Le signataire affirme l'absence d'informations défavorables substantielles non divulguées.

LeMaitre Vascular, Inc. In der Form 144 wird ein geplanter Verkauf von 2.500 Stammaktien an der NASDAQ über Morgan Stanley Smith Barney LLC gemeldet, mit einem Gesamtmarktwert von $235.000 und einem voraussichtlichen Verkaufstermin am 08/08/2025. Die Einreichung nennt 22.637.522 ausstehende Aktien, was zeigt, dass der gemeldete Verkauf einen sehr kleinen Anteil des ausstehenden Aktienbestands darstellt.

Die zu veräußernden Wertpapiere sind als durch Ausübung einer Aktienoption am 08/08/2025 erworben mit Zahlung in Bargeld verbucht. Die Einreichung nennt außerdem einen früheren Verkauf durch Bridget A Ross von 3.750 Aktien am 05/12/2025 für $312.000. Mehrere Identifikationsfelder des Einreichenden (z. B. Filer CIK und Filer CCC) sind im bereitgestellten Text nicht ausgefüllt. Der Unterzeichner bestätigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine insider option exercise and sale; transaction size is negligible relative to outstanding shares, so likely neutral market impact.

The Form 144 documents a sale of 2,500 shares valued at $235,000. With 22,637,522 shares outstanding the sale equals roughly 0.011% of outstanding shares, which is immaterial in size and unlikely to affect liquidity or valuation. The shares were acquired the same day via a stock option exercise and paid in cash, and the sale will be executed through Morgan Stanley Smith Barney LLC. The filing also discloses a prior related sale of 3,750 shares on 05/12/2025. Overall this constitutes routine insider activity rather than a material corporate event.

TL;DR: Filing appears procedurally compliant with Rule 144 disclosures; missing filer identification fields are noted in the provided text.

The notice includes the required representations, including a signers declaration that no undisclosed material adverse information exists. The transaction details state acquisition via a stock option exercise and sale through an identified broker on 08/08/2025. The provided excerpt lacks some administrative filer identifiers (for example Filer CIK and Filer CCC appear blank), which are important for tracing the filer but do not change the reported economic facts. Impact on governance or control appears minimal based on the stated quantities.

LeMaitre Vascular, Inc. La Form 144 segnala una proposta di vendita di 2.500 azioni ordinarie su NASDAQ tramite Morgan Stanley Smith Barney LLC, per un valore di mercato complessivo di $235.000 e con data approssimativa di vendita indicata come 08/08/2025. Il deposito riporta 22.637.522 azioni in circolazione, mostrando che la vendita segnalata rappresenta una quota molto ridotta del capitale sociale della società.

I titoli da vendere risultano acquisiti mediante esercizio di un'opzione azionaria il 08/08/2025 con pagamento in contanti. La documentazione segnala inoltre una precedente vendita effettuata da Bridget A Ross di 3.750 azioni in data 05/12/2025 per $312.000. Alcuni campi identificativi del dichiarante (ad esempio Filer CIK e Filer CCC) non sono compilati nel testo fornito. Il firmatario dichiara l'assenza di informazioni materiali sfavorevoli non divulgate.

LeMaitre Vascular, Inc. El Form 144 informa de una propuesta de venta de 2.500 acciones ordinarias en NASDAQ a través de Morgan Stanley Smith Barney LLC, con un valor de mercado agregado de $235,000 y una fecha aproximada de venta de 08/08/2025. La presentación indica 22.637.522 acciones en circulación, lo que muestra que la venta notificada constituye una fracción muy pequeña del capital social de la compañía.

Los valores a vender constan como adquiridos mediante el ejercicio de una opción sobre acciones el 08/08/2025, con pago en efectivo. El documento también revela una venta previa por parte de Bridget A Ross de 3.750 acciones el 05/12/2025 por $312,000. Varios campos de identificación del declarante (por ejemplo Filer CIK y Filer CCC) no aparecen completados en el texto facilitado. El firmante afirma que no existen informaciones adversas materiales no divulgadas.

LeMaitre Vascular, Inc.Form 144Morgan Stanley Smith Barney LLC를 통해 NASDAQ에서 2,500 보통주 매각을 제안했음을 보고하며, 총 시가가 $235,000이고 예상 매각일은 08/08/2025로 명시되어 있습니다. 제출서류에는 22,637,522주가 유통 중으로 기재되어 있어 보고된 매각이 회사 발행주식의 매우 작은 부분임을 보여줍니다.

매도 예정 증권은 스톡옵션 행사08/08/2025에 취득된 것으로 기록되어 있으며, 대금은 현금으로 지급되었습니다. 서류는 또한 Bridget A Ross05/12/20253,750주를 $312,000에 매각한 사실도 공개하고 있습니다. 제출자 식별 필드(예: Filer CIK 및 Filer CCC) 중 일부가 제공된 텍스트에 기입되어 있지 않습니다. 서명자는 공개되지 않은 중대한 불리한 정보가 없음을 확인합니다.

LeMaitre Vascular, Inc. Le Form 144 signale une proposition de vente de 2 500 actions ordinaires sur le NASDAQ par l'intermédiaire de Morgan Stanley Smith Barney LLC, pour une valeur de marché totale de 235 000 $ et une date approximative de vente le 08/08/2025. Le dossier indique 22 637 522 actions en circulation, montrant que la vente déclarée ne représente qu'une très petite fraction du capital social de la société.

Les titres à vendre sont indiqués comme ayant été acquis par exercice d'une option sur actions le 08/08/2025, avec paiement en espèces. Le dossier révèle également une vente antérieure réalisée par Bridget A Ross de 3 750 actions le 05/12/2025 pour 312 000 $. Plusieurs champs d'identification du déclarant (par exemple Filer CIK et Filer CCC) ne sont pas remplis dans le texte fourni. Le signataire affirme l'absence d'informations défavorables substantielles non divulguées.

LeMaitre Vascular, Inc. In der Form 144 wird ein geplanter Verkauf von 2.500 Stammaktien an der NASDAQ über Morgan Stanley Smith Barney LLC gemeldet, mit einem Gesamtmarktwert von $235.000 und einem voraussichtlichen Verkaufstermin am 08/08/2025. Die Einreichung nennt 22.637.522 ausstehende Aktien, was zeigt, dass der gemeldete Verkauf einen sehr kleinen Anteil des ausstehenden Aktienbestands darstellt.

Die zu veräußernden Wertpapiere sind als durch Ausübung einer Aktienoption am 08/08/2025 erworben mit Zahlung in Bargeld verbucht. Die Einreichung nennt außerdem einen früheren Verkauf durch Bridget A Ross von 3.750 Aktien am 05/12/2025 für $312.000. Mehrere Identifikationsfelder des Einreichenden (z. B. Filer CIK und Filer CCC) sind im bereitgestellten Text nicht ausgefüllt. Der Unterzeichner bestätigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for LMAT report?

The Form 144 reports a proposed sale of 2,500 common shares on NASDAQ through Morgan Stanley Smith Barney LLC for an aggregate market value of $235,000 with approximate sale date 08/08/2025.

How were the 2,500 LMAT shares acquired?

The filing states the 2,500 shares were acquired via a stock option exercise on 08/08/2025 and payment was made in cash.

Has the filer sold LMAT shares recently?

Yes. The document shows Bridget A Ross sold 3,750 shares on 05/12/2025 for gross proceeds of $312,000.

What broker is handling the proposed sale?

The sale is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza 8th Floor New York NY 10004.

Are issuer and filer identification fields complete in the provided filing excerpt?

No. Several administrative fields such as Filer CIK and Filer CCC are not populated in the provided text.
Lemaitre Vasculr

NASDAQ:LMAT

LMAT Rankings

LMAT Latest News

LMAT Latest SEC Filings

LMAT Stock Data

2.11B
20.66M
8.83%
95.6%
6.09%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
BURLINGTON